Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2014

Jun 25, 2014

10216_dirs_2014-06-24_8493f74e-5bda-4326-9462-d88c56ae0cf1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24

Reporting Person: Koo Richard (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 204365 Direct
Common Stock 5457 Direct
Common Stock 10000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $14.66 2018-12-20 Common Stock (29278) Direct

Footnotes

F1: This represents deferred stock units that were granted on 12/20/2013 and fully vest on the first anniversary of the grant date, subject to the reporting person's continued service on the Board of Directors of the Issuer through the vesting date.

F2: Reflects shares owned by Richard Y. Koo, a sole proprietorship, of which the Reporting Person is the sole owner.

F3: This option was granted on 12/20/2013 and fully vests on the first anniversary of the grant date, subject to the reporting person's continued service on the Board of Directors of the Issuer through the vesting date.